TY  - JOUR

T1  - IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer

JO  - npj Breast Cancer

PY  - 2021/07/21

AU  - Tulotta C

AU  - Lefley DV

AU  - Moore CK

AU  - Amariutei AE

AU  - Spicer-Hadlington AR

AU  - Quayle LA

AU  - Hughes RO

AU  - Ahmed K

AU  - Cookson V

AU  - Evans CA

AU  - Vadakekolathu J et al

ED  - 

DO  - DOI: 10.1038/s41523-021-00305-w

PB  - Springer Science and Business Media LLC

VL  - 7

IS  - 1

Y2  - 2024/12/22

ER  -